Miguel Montero-Baker

Dr Ysa has been a Vascular and Endovascular Surgery Consultant in Hospital de Cruces (Barakaldo. Spain) since 2003. His Department is a well known institution in the endovascular management of CLTI patients. He developed his Vascular Fellowship Programme in Hospital del Mar (Barcelona. Spain) and thereafter completed his training with short stages in Montefiore Hospital (F. Veith. NY. USA) and Houston Methodist Hospital (TX. USA). In 2006 he became Fellow of the European Board of Vascular Surgery and in 2011 he joined St Mary´s Hospital (London. UK) as a Senior Specialist Registrar.
For the last ten years his activity has been mainly focussed in the endovascular treatment of the lower limbs, being the co-director of the complex BTK/BTA revascularization Unit of his Department. He is also a reviewer of the Annals of Vascular Surgery and Journal of Endovascular Therapy since 2008 and 2019.
His Unit has presented multiple communications in well-recognized international symposiums and has published many papers in first-line journals of his specialty. In 2020, his clip “ Proximal venous arterialization using conventional “off-the-shelf” devices” was awarded as the most innovative video of the European Society in Vascular Surgery Masterclass.

Dr. Khanjan “KJ” Nagarsheth is a vascular surgeon, Professor of Surgery, and Chief of the Division of Vascular Surgery at St. Louis University School of Medicine, where he also serves as System Director of Vascular Surgery for SSM Health in the St. Louis region. He is board certified in Vascular Surgery, General Surgery, and Surgical Critical Care. Dr. Nagarsheth completed his general surgery training at the University of Tennessee, fellowships in Surgical Critical Care and Acute Care Surgery at the R Adams Cowley Shock Trauma Center and University of Maryland, and vascular surgery fellowship training at Staten Island University Hospital/Northwell. He also earned an MBA in Entrepreneurship from the University of North Carolina at Chapel Hill.

Dr. Nagarsheth has developed nationally recognized programs in limb preservation, venous disease, vascular compression syndromes, pulmonary embolism care, and outpatient vascular interventions. His clinical and research interests focus on peripheral arterial disease, advanced venous disease, wound healing, thrombosis, and limb salvage innovation. He has authored more than 110 peer reviewed publications, multiple textbook chapters, and serves in numerous national leadership and editorial roles, including Associate Editor and Social Media Editor for the Journal of Vascular Surgery Cases and Innovative Techniques. He is an active mentor to medical students, residents, and fellows and is committed to advancing multidisciplinary vascular care, surgical education, and healthcare innovation.

Mary Costantino MD, FSIR is a Interventional Radiologist in Portland, Oregon. She is the Owner/Operator at Advanced Vascular Centers, Portland and co-owner of Advanced Vascular Centers, Eugene. She has been in the outpatient arena since 2011. Her practice is focused on llimb salvage, uterine fibroids and venous disease.

Michael Siah, M.D., is an Associate Professor in the Department of Surgery at UT Southwestern Medical Center. He is a board-certified vascular surgeon and has been practicing at UT Southwestern since 2019.

Dr. Siah earned his medical degree at the University of Hawaii’s John A. Burns School of Medicine and completed a residency in vascular surgery at Georgetown University Hospital/Washington Hospital Center. He has delivered a number of presentations and published several academic articles and book chapters.

Additionally, he is Director of the Limb Salvage Program in the Division of Vascular and Endovascular Surgery at UT Southwestern. His primary clinical focus is on therapies for peripheral vascular disease, diabetic limb salvage, complex deep venous disease, and carotid disease.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Dr. Miguel Montero-Baker is a renowned vascular and endovascular surgeon, recognized for his expertise in peripheral arterial disease. With his Advanced Endovascular Therapies fellowship from the University of Leipzig, American Board of Vascular Surgery certification from the University of Arizona and a Medical Degree from the University of Costa Rica, he has held prominent roles including Associate Professor at Baylor College of Medicine, Chief of Vascular Surgery at The Houston Methodist Hospital, and Medical Director at HOPE Vascular & Podiatry, Houston. As CEO of HENDOSYN, he leads early feasibility studies for vascular medical technologies in Latin America. In 2023, he launched a successful podcast on vascular care (Life Of Flow), further solidifying his position as a key opinion leader and consultant in endovascular therapy. His innovative contributions and international experiences position him at the forefront of lower limb intervention advancements.

Dr Kum received his medical degree from the National University of Singapore in 2000 and
subsequently embarked on his surgical training with the Royal College of Surgeons,
obtaining his Master of Medicine and Fellowship in 2007.
In 2009, he completed his Postgraduate Fellowship in Vascular and Endovascular Surgery at
the Prince of Wales Hospital, Sydney as well as at the Department of Angiology, Heart
Centre Leipzig. In 2012, he completed a second Fellowship on Advanced Techniques in
Diabetic Limb Salvage and Wound Care Techniques in Milan.
Since 2015, Dr Kum has been the Director of Vascular Surgery at Department of Surgery,
Changi General Hospital Singapore and he was subsequently appointed as a Visiting
Consultant in 2019. He currently maintains his practice at Mount Elizabeth Novena
Hospital, Singapore and is currently the CMO of M & L Healthcare. Dr Kum is the past President of the
Society for Vascular and Endovascular Surgeons of Singapore (SVESS) and is part of the organizing committee of
Critical Issues in Endovascular Therapy, a regional meeting organized by the society.
Dr Kum has a keen interest in clinical research revolving around Diabetic Limb Salvage. He is
one of the pioneers in Percutaneous Deep Arterialization for no-option Critical Limb
Ischemia for which he has authored or co-authored numerous papers. He is the PI or co-PI
for several industry or physician led studies. He is also a keen innovator who is currently
working on several disruptive technologies.